ASIMOV AND EMERGENT BIOSOLUTIONS ANNOUNCE CELL LINE DEVELOPMENT PARTNERSHIP TO ADVANCE NOVEL ANTIBODIES AGAINST EBOLA

Reuters · 1d ago

Please log in to view news